Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Down – Here’s Why

Shares of Eurofins Scient (OTCMKTS:ERFSF) gapped down prior to trading on Wednesday . The stock had previously closed at $81.76, but opened at $78.44. Eurofins Scient shares last traded at $81.11, with a volume of 145 shares traded.

Wall Street Analyst Weigh In

ERFSF has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Eurofins Scient in a research report on Wednesday, October 29th. Citigroup reaffirmed a “neutral” rating on shares of Eurofins Scient in a research note on Wednesday, October 22nd. Finally, BNP Paribas raised Eurofins Scient to an “outperform” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Eurofins Scient has a consensus rating of “Hold”.

Eurofins Scient Stock Performance

The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77. The business’s 50-day moving average is $70.69 and its two-hundred day moving average is $73.06.

About Eurofins Scient

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.